Award recordCONTRACT

OTSUKA AMERICA PHARMACEUTICAL INC

PIID 36C26222F0276· VHA· 262-NETWORK CONTRACT OFFICE 22 (36C262)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $137,108 net obligations· UEI QKABLBMA8FT9· MD

Description

TOLVAPTAN (JYNARQUE) - MEDICATION FOR DIRECT PATIENT CARE (2)

First action · last action
2022-04-08 · 2024-01-04
Transactions
2
First transaction's obligation
$159,960
Base + all options value (sum of deltas)
$297,068
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0099
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$159,960$0Base award · 2022-04-08 · this action $159,960 · running total $159,960Modification P00001 · 2024-01-04 · this action -$22,851 · running total $137,108
  • Base2022-04-08+$159,960= $159,960
  • Mod P000012024-01-04-$22,851= $137,108
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-04-08+$159,960$159,960TOLVAPTAN (JYNARQUE) - MEDICATION FOR DIRECT PATIENT CARE (2)
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-01-04−$22,851$137,108TOLVAPTAN (JYNARQUE) - MEDICATION FOR DIRECT PATIENT CARE (2)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI QKABLBMA8FT9)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0783245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$20,378FY2026
36C24525N0988245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24525N0987245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0901245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0789245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0683245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26226N0873CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$140,823FY2026
36C26226N0871CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$231,746FY2026
36C26226N0870CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$167,369FY2026
36C26226N0872CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$164,265FY2026
36C26226P1412ASD SPECIALTY HEALTHCARE, LLC262-NETWORK CONTRACT OFFICE 22 (36C262)$38,220FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26222F0276_3600_36F79720D0099_3600 · retrieved 2026-09-26.